Johnson & Johnson’s Zytiga helps men newly diagnosed with advanced prostate cancer live longer, according to new findings that could expand use of the medication. Men who received hormone therapy, the recommended first-time treatment, plus Zytiga were about one-third less likely to die during two studies than those who got standard treatment alone, according to research…
The impact exercise has on surviving many common cancers can’t be ignored, with Australian research showing the risk of dying may be reduced by nearly a half by regularly walking and lifting moderate weights. A review of more than 100 studies involving tens of thousands of cancer patients worldwide published in the American Journal of…
This is the first of (hopefully!) a series of blog posts by New Zealand specialists in prostate cancer treatment. Today we have Zee Sharif, a Physiotherapist at Return To Form in Auckland. Life After Prostate Cancer -How Can Physiotherapy Help? All mammals have a prostate gland – however for unknown reasons it only causes problems…
SAN FRANCISCO, April 3, 2017 — On the list of dreaded medical tests, a prostate biopsy probably ranks fairly high. The common procedure requires sticking a needle into the prostate gland to remove tissue for assessment. Thousands of men who undergo the uncomfortable procedure, prompted by a positive PSA (prostate-specific antigen) test, ultimately don’t require…
© 2023 Prostate Cancer Foundation
